|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007131,
umls-concept:C0032207,
umls-concept:C0036043,
umls-concept:C0087111,
umls-concept:C0144576,
umls-concept:C0205179,
umls-concept:C0205195,
umls-concept:C0246415,
umls-concept:C0332174,
umls-concept:C2347660,
umls-concept:C2603343
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2010-3-2
|
|
pubmed:abstractText |
To evaluate the efficacy and safety of a weekly taxane schedule in the treatment of advanced non small cell lung cancers (NSCLCs) and to generate an optimal pre-medication protocol for weekly taxane.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1513-7368
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1147-50
|
|
pubmed:meshHeading |
pubmed-meshheading:20192601-Adult,
pubmed-meshheading:20192601-Aged,
pubmed-meshheading:20192601-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20192601-Carboplatin,
pubmed-meshheading:20192601-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:20192601-Cisplatin,
pubmed-meshheading:20192601-Female,
pubmed-meshheading:20192601-Humans,
pubmed-meshheading:20192601-Lung Neoplasms,
pubmed-meshheading:20192601-Male,
pubmed-meshheading:20192601-Middle Aged,
pubmed-meshheading:20192601-Organoplatinum Compounds,
pubmed-meshheading:20192601-Paclitaxel,
pubmed-meshheading:20192601-Premedication,
pubmed-meshheading:20192601-Taxoids,
pubmed-meshheading:20192601-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Weekly paclitaxel/ docetaxel combined with a platinum in the treatment of advanced non-small cell lung cancer: a study on efficacy, safety and pre-medication.
|
|
pubmed:affiliation |
Department of General Surgery and Chemotherapy, Jiangsu Cancer Hospital and Research Institute, Nanjing, Jiangsu Province, China. zhoujiannong09@yahoo.com.cn
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
